How a different look at latency can help to develop novel diagnostics and vaccines against tuberculosis (Q36981662)

17 August 2017

1 reference

title

How a different look at latency can help to develop novel diagnostics and vaccines against tuberculosis (English)

1 reference

17 August 2017

1 reference

1

Camille Locht

1 reference

17 August 2017

Carine Rouanet

2

1 reference

17 August 2017

Jean-Michel Hougardy

series ordinal

3

1 reference

17 August 2017

Françoise Mascart

series ordinal

4

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 November 2007

1 reference

Expert Opinion on Biological Therapy

17 August 2017

1 reference

17 August 2017

7

1 reference

17 August 2017

11

1 reference

17 August 2017

1665-1677

1 reference

Evolution of Tuberculosis Control and Prospects for Reducing Tuberculosis Incidence, Prevalence, and Deaths Globally

17 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Review of Human Immunodeficiency Virus Type 1–Related Opportunistic Infections in Sub‐Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Controlling tuberculosis in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Global incidence of multidrug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Treatment of multidrug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Worldwide emergence of extensively drug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Variation in protection by BCG: implications of and for heterologous immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Tuberculosis vaccines: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Genome plasticity of BCG and impact on vaccine efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Mycobacterium tuberculosis: here today, and here tomorrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Who puts the tubercle in tuberculosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Is adipose tissue a place for Mycobacterium tuberculosis persistence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Does the risk of tuberculosis increase in old age?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

CD8+ T cells in tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Lessons from experimental Mycobacterium tuberculosis infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Dormancy of Mycobacterium tuberculosis and latency of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

On the nature of Mycobacterium tuberculosis-latent bacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Nonreplicating persistence of mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding α-crystallin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Human T- and B-cell reactivity to the 16kDa alpha-crystallin protein of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Growth characteristics of tubercle bacilli and certain other mycobacteria in HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

The efficiency of the translocation of Mycobacterium tuberculosis across a bilayer of epithelial and endothelial cells as a model of the alveolar wall is a consequence of transport within mononuclear phagocytes and invasion of alveolar epithelial ce

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Identification of a heparin-binding hemagglutinin present in mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Molecular characterization of the mycobacterial heparin-binding hemagglutinin, a mycobacterial adhesin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Characterization of the heparin-binding site of the mycobacterial heparin-binding hemagglutinin adhesin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Mycobacterial heparin-binding hemagglutinin and laminin-binding protein share antigenic methyllysines that confer resistance to proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Enzymatic methylation of the Mycobacterium tuberculosis heparin-binding haemagglutinin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Decreased infectivity despite unaltered C3 binding by a DeltahbhA mutant of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Mycobacterium tuberculosis heparin-binding haemagglutinin adhesin (HBHA) triggers receptor-mediated transcytosis without altering the integrity of tight junctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Pathogenesis of tuberculosis: pathway to apical localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

The hbhA gene of Mycobacterium tuberculosis is specifically upregulated in the lungs but not in the spleens of aerogenically infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Clinical practice. Latent tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

An update on the diagnosis of tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Regulatory T cells depress immune responses to protective antigens in active tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Transforming growth factor beta at clinical onset of Type 1 diabetes mellitus. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Transforming growth factor-beta (TGF-beta) in silicosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Effector functions of heparin-binding hemagglutinin-specific CD8+ T lymphocytes in latent human tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Heparin-binding hemagglutinin, from an extrapulmonary dissemination factor to a powerful diagnostic and protective antigen against tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

The mycobacterial heparin-binding hemagglutinin is a protective antigen in the mouse aerosol challenge model of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Nanoscale mapping and functional analysis of individual adhesins on living bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Priorities for the Treatment of Latent Tuberculosis Infection in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1665

10.1517/14712598.7.11.1665

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference